INNOVATE-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz)concomitant with weekly paclitaxel for the treatment of platinum-resistant ovarian cancer (PROC)

Project: Research project

Project Details

Description

INNOVATE-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz) concomitant with weekly paclitaxel for the treatment of platinum-resistant ovarian cancer (PROC)
StatusActive
Effective start/end date8/15/19 → 8/31/24

Funding

  • NOVOCURE INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint